Head neck squamous cell carcinoma c-Met+ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis

International Journal of Cancer

Volumn 129, Issue 10, 2011, Pages 2337-2348

  Sun, Shuyang ^a   Wang, Zuolin ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

c Met; cancer stem cell marker; chemoresistance; head neck squamous cell carcinoma; metastasis

Indexed keywords

CISPLATIN; HERMES ANTIGEN; LENTIVIRUS VECTOR; LUCIFERASE; SCATTER FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STEM CELL; CARCINOGENICITY; CELL ISOLATION; CELL POPULATION; CELL RENEWAL; CELL SEPARATION; CONTROLLED STUDY; DRUG ACTIVITY; HEAD AND NECK CARCINOMA; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE COUNT; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; PROTO-ONCOGENE PROTEINS C-MET; TUMOR MARKERS, BIOLOGICAL;

EID: 80052971224     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25927     Document Type: Article

References (47)

1. Lothaire P, De Azambuja E, Dequanter D, Lalami Y, Sotiriou C, Andry G, Castro G, Jr, Awada A,. Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation. Head Neck 2006; 28: 256-69. (Pubitemid 43269893)
2. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE,. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645-8. (Pubitemid 24067706)
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF,. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-8. (Pubitemid 36418143)
4. Rich JN, Bao S,. Chemotherapy and cancer stem cells. Cell Stem Cell 2007; 1: 353-5. (Pubitemid 47506543)
5. Diehn M, Clarke MF,. Cancer stem cells and radiotherapy: new insights into tumor radioresistance. J Natl Cancer Inst 2006; 98: 1755-7. (Pubitemid 46017927)
6. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE,. Identification of a subpopulation of cells with cancer stem cells properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 2007; 104: 973-8. (Pubitemid 46154721)
7. Chen YC, Chen YW, Hsu HS, Tseng LM, Huang PI, Lu KH, Chen DT, Tai LK, Yung MC, Chang SC, Ku HH, Chiou SH, et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun 2009; 385: 307-13.
8. Clay MR, Tabor M, Owen JH, Carey TE, Bradford CR, Wolf GT, Wicha MS, Prince ME,. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 2010; 32: 1195-201.
9. Chen YC, Chang CJ, Hsu HS, Chen YW, Tai LK, Tseng LM, Chiou GY, Chang SC, Kao SY, Chiou SH, Lo WL,. Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1. Oral Oncol 2010; 46: 158-65.
10. Gentile A, Trusolino L, Comoglio PM,. The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev 2008; 27: 85-94.
11. Chu SH, Feng DF, Zhang H, Chen ET, Duan ZX, Li XY, Li J, Ma YB, Zhu ZA, Qiu JH,. c-Met-targeted RNA interference inhibits growth and metastasis of glioma U251 cells in vitro. J Neurooncol 2009; 93: 183-9.
12. Merlin S, Pietronave S, Locarno D, Valente G, Follenzi A, Prat M,. Deletion of the ectodomain unleashes the transforming, invasive, and tumorigenic potential of the MET oncogene. Cancer Sci 2009; 100: 633-8.
13. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF,. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003; 4: 915-25. (Pubitemid 37493640)
14. You WK, McDonald DM,. The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis. BMB Rep 2008; 41: 833-9.
15. De Herdt MJ, Baatenburg de Jong RJ,. HGF and c-MET as potential orchestrators of invasive growth in head and neck squamous cell carcinoma. Front Biosci 2008; 13: 2516-26. (Pubitemid 351599701)
16. Di Renzo MF, Olivero M, Martone T, Maffe A, Maggiora P, Stefani AD, Valente G, Giordano S, Cortesina G, Comoglio PM,. Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas. Oncogene 2000; 19: 1547-55. (Pubitemid 30175676)
17. Shah AN, Summy JM, Zhang J, Park SI, Parikh NU, Gallick GE,. Development and characterization of gemcitabine-resistant pancreatic tumor cells. Ann Surg Oncol 2007; 14: 3629-37. (Pubitemid 350160137)
18. Bean J, Brennan C, Shih JY, Riely G, Viale A, Wang L, Chitale D, Motoi N, Szoke J, Broderick S, Balak M, Chang WC, et al. MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib. Proc Natl Acad Sci USA 2007; 104: 20932-7.
19. Shattuck DL, Miller JK, Carraway KL 3rd, Sweeney C,. Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells. Cancer Res 2008; 68: 1471-7. (Pubitemid 351346855)
20. Chen JT, Huang CY, Chiang YY, Chen WH, Chiou SH, Chen CY, Chow KC,. HGF increases cisplatin resistance via down-regulation of AIF in lung cancer cells. Am J Respir Cell Mol Biol 2008; 38: 559-65.
21. Boccaccio C, Comoglio PM,. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer 2006; 6: 637-45. (Pubitemid 44140861)
22. Teng C, Guo Y, Zhang H, Zhang H, Ding M, Deng H,. Identification and characterization of label-retaining cells in mouse pancreas. Differentiation 2007; 75: 702-12. (Pubitemid 47537523)
23. Kamiya A, Gonzalez FJ, Nakauchi H,. Identification and differentiation of hepatic stem cells during liver development. Front Biosci 2006; 11: 1302-10. (Pubitemid 43253423)
24. Urbanek K, Rota M, Cascapera S, Bearzi C, Nascimbene A, De Angelis A, Hosoda T, Chimenti S, Baker M, Limana F, Nurzynska D, Torella D, et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 2005; 97: 663-73. (Pubitemid 41416335)
25. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-67. (Pubitemid 350056407)
26. Reynolds BA, Weiss S,. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 1996; 175: 1-13. (Pubitemid 26150042)
27. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS,. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003; 17: 1253-70. (Pubitemid 36583168)
28. Ishibashi S, Sakaguchi M, Kuroiwa T, Yamasaki M, Kanemura Y, Shizuko I, Shimazaki T, Onodera M, Okano H, Mizusawa H,. Human neural stem/progenitor cells, expanded in long-term neurosphere culture, promote functional recovery after focal ischemia in Mongolian gerbils. J Neurosci Res 2004; 78: 215-23. (Pubitemid 39313794)
29. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R,. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-15. (Pubitemid 46067311)
30. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM,. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006; 66: 9339-44. (Pubitemid 44623625)
31. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C,. Distinct populations of cancer stem cells determined tumor growth and metastatic activity in human panreatic cancer. Cell Stem Cell 2007; 1: 313-23. (Pubitemid 47355323)
32. Blanpain C, Horsley V, Fuchs E,. Epithelial stem cells: turning over new leaves. Cell 2007; 128: 445-458. (Pubitemid 46198895)
33. Haupt Y, Bath ML, Harris AW, Adams JM,. Bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis. Oncogene 1993; 8: 3161-4. (Pubitemid 23312924)
34. Kim JH, Yoon SY, Jeong SH, Kim SY, Moon SK, Joo JH, Lee Y, Choe IS, Kim JW,. Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast 2004; 13: 383-8. (Pubitemid 39549787)
35. Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL, Shao JY, Wu QL, Li MZ, Xia YF, Fu LW, Huang WL, et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 2006; 66: 6225-32.
36. Kang MK, Kim RH, Kim SJ, Yip FK, Shin KH, Dimri GP, Christensen R, Han T, Park NH,. Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer 2007; 96: 126-33. (Pubitemid 46094649)
37. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, Morrison SJ, Clarke MF,. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003; 423: 302-5. (Pubitemid 40852701)
38. Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, Suri P, Wicha MS,. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 2006; 66: 6063-71.
39. Simeone DM,. Pancreatic cancer stem cells: implications for the treatment of pancreatic cancer. Clin Cancer Res 2008; 14: 5646-8.
40. Liu Y, Chattopadhyay N, Qin S, Szekeres C, Vasylyeva T, Mahoney ZX, Taglienti M, Bates CM, Chapman HA, Miner JH, Kreidberg JA,. Coordinate integrin and c-Met signaling regulate Wnt gene expression during epithelial morphogenesis. Development 2009; 136: 843-53.
41. Ohnishi T, Daikuhara Y,. Hepatocyte growth factor/scatter factor in development, inflammation and carcinogenesis: its expression and role in oral tissues. Arch Oral Biol 2003; 48: 797-804. (Pubitemid 37400041)
42. Kanayama M, Takahara T, Yata Y, Xue F, Shinno E, Nonome K, Kudo H, Kawai K, Kudo T, Tabuchi Y, Watanabe A, Sugiyama T,. Hepatocyte growth factor promotes colonic epithelial regeneration via Akt signaling. Am J Physiol Gastrointest Liver Physiol 2007; 293: G230-9. (Pubitemid 47105174)
43. Gao CF, Vande Woude GF,. HGF/SF-Met signaling in tumor progression. Cell Res 2005; 15: 49-51. (Pubitemid 41653965)
44. Vermeulen L, De Sousa E, Melo F, van der Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M, Merz C, Rodermond H, Sprick MR, Kemper K, et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010; 12: 468-76.
45. Munshi N, Jeay S, Li Y, Chen CR, France DS, Ashwell MA, Hill J, Moussa MM, Leggett DS, Li CJ,. ARQ 197, a novel and selective inhibitor of the human c-Met receptor tyrosine kinase with antitumor activity. Mol Cancer Ther 2010; 9: 1544-53.
46. Cañadas I, Rojo F, Arumí-Uría M, Rovira A, Albanell J, Arriola E,. C-MET as a new therapeutic target for the development of novel anticancer drugs. Clin Transl Oncol 2010; 12: 253-60.
47. Knowles LM, Stabile LP, Egloff AM, Rothstein ME, Thomas SM, Gubish CT, Lerner EC, Seethala RR, Suzuki S, Quesnelle KM, Morgan S, Ferris RL, et al. HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer. Clin Cancer Res 2009; 15: 3740-50.